New York regulators expand access to medical marijuana program
Marijuana Industry NewsMedical MarijuanaNew York January 25, 2022 MJ Shareholders 0
Marijuana will be easier to prescribe and use for medical purposes in New York under recently finalized regulatory changes.
The state Office of Cannabis Management said the new certification and registration system officially announced Monday eliminates the list of qualifying conditions — a patient can now be certified for medical marijuana use for any condition that the health care practitioner believes would benefit from such therapy.
The change is the latest in a series of changes underway as the state continues its transition toward legal, regulated marijuana production and sale.
Oversight of the medical marijuana program previously was transferred from the state Department of Health to the Office of Cannabis Management.
The OCM already has allowed the sale of whole flower for medical purposes, rather than just extracts. Also last year, it expanded the list of medical professionals able to certify patients to any practitioner licensed to prescribe controlled substances; permanently waived the $50 registration fee for patient and caregiver; and increased from 30 to 60 days the supply that can be dispensed.
The medical marijuana program got off to a slow start in New York after it was authorized in 2014 and drew criticism as being heavily regulated, expensive, cumbersome and limited in product selection. [Read more at The Daily Gazette]
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.